EQS-DD: aap Implantate AG: Merval AG, Purchase of shares through the exercise of conversion rights

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 17.12.2024 / 12:31 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Name and legal form: Merval AG 2. Reason for the notification a) Position / status Person closely associated with: Title: Dr. med. First name: Nathalie Last name(s): Krebs Position: Member of the administrative or supervisory body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name aap Implantate AG b) LEI 39120001TRQTQ01LPP57  4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Financial instrument linked to a share or a debt instrument ISIN: DE000A351ZH9 b) Nature of the transaction Purchase of shares through the exercise of conversion rights c) Price(s) and volume(s) Price(s) Volume(s) 1.03 EUR 149999.93 EUR d) Aggregated information Price Aggregated volume 1.03 EUR 149999.93 EUR e) Date of the transaction 11/06/2024; UTC+1 f) Place of the transaction Outside a trading venue 17.12.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	aap Implantate AG
	Lorenzweg 5
	12099 Berlin
	Germany
Internet:	www.aap.de

End of News	EQS News Service

95999  17.12.2024 CET/CEST